GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mayinglong Pharmaceutical Group Co Ltd (SHSE:600993) » Definitions » Scaled Net Operating Assets

Mayinglong Pharmaceutical Group Co (SHSE:600993) Scaled Net Operating Assets : 0.26 (As of Sep. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Mayinglong Pharmaceutical Group Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Mayinglong Pharmaceutical Group Co's operating assets for the quarter that ended in Sep. 2024 was ¥2,111 Mil. Mayinglong Pharmaceutical Group Co's operating liabilities for the quarter that ended in Sep. 2024 was ¥749 Mil. Mayinglong Pharmaceutical Group Co's Total Assets for the quarter that ended in Jun. 2024 was ¥5,193 Mil. Therefore, Mayinglong Pharmaceutical Group Co's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was 0.26.


Mayinglong Pharmaceutical Group Co Scaled Net Operating Assets Historical Data

The historical data trend for Mayinglong Pharmaceutical Group Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mayinglong Pharmaceutical Group Co Scaled Net Operating Assets Chart

Mayinglong Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.35 0.33 0.24 0.26 0.21

Mayinglong Pharmaceutical Group Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.31 0.22 0.27 0.22 0.26

Competitive Comparison of Mayinglong Pharmaceutical Group Co's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Mayinglong Pharmaceutical Group Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mayinglong Pharmaceutical Group Co's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mayinglong Pharmaceutical Group Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Mayinglong Pharmaceutical Group Co's Scaled Net Operating Assets falls into.



Mayinglong Pharmaceutical Group Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Mayinglong Pharmaceutical Group Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(1778.143-687.324)/5088.122
=0.21

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=4829.524 - 3051.381
=1778.143

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=959.618 - 193.587 - 78.707
=687.324

Mayinglong Pharmaceutical Group Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Sep. 2024 )
=(Operating Assets (Q: Sep. 2024 )-Operating Liabilities (Q: Sep. 2024 ))/Total Assets (Q: Jun. 2024 )
=(2110.985-749.219)/5193.331
=0.26

where

Operating Assets(Q: Sep. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=5124.759 - 3013.774
=2110.985

Operating Liabilities(Q: Sep. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=994.307 - 80.615 - 164.473
=749.219

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mayinglong Pharmaceutical Group Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Mayinglong Pharmaceutical Group Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Mayinglong Pharmaceutical Group Co Business Description

Traded in Other Exchanges
N/A
Address
No. 100 Zhoujiawan, Nanhu, Wuchang District, Wuhan, Hubei, CHN, 430064
Mayinglong Pharmaceutical Group Co Ltd is a China-based company mainly involved in pharmaceutical development, retailing and wholesaling. The company provides ointments, suppositories, and tablets for hemorrhoids.

Mayinglong Pharmaceutical Group Co Headlines

No Headlines